US FDA lifts clinical hold on Rocket Pharmaceuticals' gene therapy trial-March 2024-www.financetom.com

US FDA lifts clinical hold on Rocket Pharmaceuticals' gene therapy trial

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA lifts clinical hold on Rocket Pharmaceuticals' gene therapy trial

Aug 20, 2025 4:32 AM

Aug 20 (Reuters) - Rocket Pharmaceuticals ( RCKT ) said

on Wednesday that the U.S. Food and Drug Administration has

lifted the clinical hold on its gene therapy mid-stage trial.

Previous page： Update: Levi Strauss Shares Jump on Fiscal Q1 Adjusted Earnings, Revenue Beat Next page： Market Chatter: Morgan Stanley Managing Sale of $5.2 Billion of Loans by Failed Greek Banks

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Update: Levi Strauss Shares Jump on Fiscal Q1 Adjusted Earnings, Revenue Beat

Apr 4, 2024

12:22 PM EDT, 04/04/2024 (MT Newswires) -- (Updates with the stock move in the headline and first paragraph.) Levi Strauss (LEVI) shares jumped 16% in recent Thursday trading, a day after the apparel maker's fiscal Q1 adjusted earnings and sales beat market expectations. The company reported fiscal Q1 adjusted earnings late Wednesday of $0.26 per diluted share, down from $0.34...

Market Chatter: Morgan Stanley Managing Sale of $5.2 Billion of Loans by Failed Greek Banks

Apr 4, 2024

12:23 PM EDT, 04/04/2024 (MT Newswires) -- Morgan Stanley ( MS ) is managing the sale of about 4.8 billion euros ($5.2 billion) of loans from a group of 13 failed Greek banks, Bloomberg reported Thursday, citing people familiar with the transaction. The transaction, comprising three portfolios of mostly nonperforming loans from the failed banks, was mandated by PQH. The...

Update: Lamb Weston Shares Slump on Lower Fiscal Q3 Adjusted Earnings, 2024 Outlook

Apr 4, 2024

12:21 PM EDT, 04/04/2024 (MT Newswires) -- (Updates to add stock move in the headline and the first paragraph.) Lamb Weston ( LW ) shares fell almost 20% in recent Thursday trading after the company reported fiscal Q3 adjusted earnings of $1.20 per diluted share, down from $1.47 a year earlier. Analysts polled by Capital IQ expected $1.45. Total sales...

Update: STAAR Surgical Shares Jump After Reporting Preliminary Fiscal Q1 Sales

Apr 4, 2024

12:25 PM EDT, 04/04/2024 (MT Newswires) -- (Updates with latest stock move in the headline and first paragraph.) STAAR Surgical ( STAA ) shares jumped more than 17% in recent Thursday trading after the company said it expects preliminary fiscal Q1 net sales to be more than $77 million. Analysts surveyed by Capital IQ are expecting $72.1 million. The company...